SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 35 filers reported holding SEELOS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $410 | -85.1% | 2,226 | -3.1% | 0.00% | – |
Q2 2023 | $2,746 | +78.5% | 2,298 | +3.2% | 0.00% | – |
Q1 2023 | $1,538 | -76.8% | 2,226 | -77.2% | 0.00% | – |
Q4 2022 | $6,626 | -72.4% | 9,743 | -58.7% | 0.00% | – |
Q3 2022 | $24,000 | +1100.0% | 23,585 | +959.5% | 0.00% | – |
Q2 2022 | $2,000 | -33.3% | 2,226 | -39.9% | 0.00% | – |
Q1 2022 | $3,000 | -95.7% | 3,703 | -91.5% | 0.00% | – |
Q4 2021 | $70,000 | +900.0% | 43,540 | +1332.7% | 0.00% | – |
Q3 2021 | $7,000 | – | 3,039 | +7692.3% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 39 | -99.5% | 0.00% | – |
Q1 2021 | $43,000 | – | 8,627 | +22020.5% | 0.00% | – |
Q4 2020 | $0 | – | 39 | +5.4% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 37 | -99.0% | 0.00% | – |
Q2 2020 | $4,000 | -33.3% | 3,678 | -70.9% | 0.00% | – |
Q1 2020 | $6,000 | – | 12,650 | +1264900.0% | 0.00% | – |
Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
Q1 2019 | $3,000 | – | 953 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENDELL JEFFREY L | 4,933,024 | $4,133,000 | 0.30% |
ACUTA CAPITAL PARTNERS, LLC | 295,896 | $248,000 | 0.12% |
Connacht Asset Management LP | 231,551 | $194,000 | 0.10% |
Uniplan Investment Counsel, Inc. | 1,564,605 | $1,310,000 | 0.08% |
AdvisorShares Investments LLC | 358,796 | $301,000 | 0.05% |
1492 Capital Management LLC | 99,819 | $84,000 | 0.04% |
Woodline Partners LP | 2,803,230 | $2,349,000 | 0.04% |
Ikarian Capital, LLC | 257,883 | $215,000 | 0.03% |
Sovereign Financial Group, Inc. | 75,000 | $63,000 | 0.02% |
Aquatic Capital Management LLC | 6,400 | $5,000 | 0.01% |